SCHRODER INVESTMENT MANAGEMENT GROUP - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2023$6,456,896
-12.2%
60,2210.0%0.01%
-16.7%
Q4 2022$7,354,791
+22.5%
60,221
+3.6%
0.01%
+20.0%
Q3 2022$6,002,000
+26.2%
58,127
+13.6%
0.01%
+42.9%
Q2 2022$4,757,000
-18.5%
51,174
+1.7%
0.01%
-12.5%
Q1 2022$5,836,000
+17.4%
50,305
+36.2%
0.01%
+33.3%
Q4 2021$4,970,000
-11.5%
36,943
+4.8%
0.01%
-33.3%
Q3 2021$5,618,000
+87.5%
35,248
+54.7%
0.01%
+125.0%
Q2 2021$2,997,000
+10.4%
22,780
+8.2%
0.00%0.0%
Q1 2021$2,714,000
-57.1%
21,057
-44.4%
0.00%0.0%
Q4 2020$6,320,000
+105.5%
37,894
+95.5%
0.00%
-20.0%
Q3 2020$3,076,000
+17.3%
19,388
+9.4%
0.01%0.0%
Q2 2020$2,622,000
+52.4%
17,729
+21.9%
0.01%
+25.0%
Q1 2020$1,720,000
-14.7%
14,538
+0.3%
0.00%
+33.3%
Q4 2019$2,016,000
+44.6%
14,4920.0%0.00%
+50.0%
Q3 2019$1,394,00014,4920.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,797,745$265,886,00019.06%
RA Capital Management 4,914,955$726,922,00014.16%
Sofinnova Investments, Inc. 1,109,874$164,150,00010.35%
Eventide Asset Management 1,709,848$252,887,0005.50%
Asymmetry Capital Management, L.P. 47,599$7,040,0005.39%
BERYLSON CAPITAL PARTNERS, LLC 58,200$8,608,0005.30%
Avoro Capital Advisors LLC 1,750,000$258,825,0005.12%
Eversept Partners, LP 220,344$32,588,8784.47%
Spyglass Capital Management LLC 452,104$66,866,0004.14%
Orbimed Advisors 1,562,986$231,166,0003.25%
View complete list of ASCENDIS PHARMA A/S shareholders